How should hyponatremia be managed in a patient with chronic kidney disease, estimated glomerular filtration rate (eGFR) 30 mL/min/1.73 m², serum sodium 122 mmol/L, and serum chloride 84 mmol/L?

Management of Severe Hyponatremia in CKD Stage 3b

This patient requires immediate evaluation for symptoms and urgent treatment if symptomatic, with careful sodium correction not exceeding 10 mEq/L in 24 hours to prevent osmotic demyelination syndrome, while simultaneously addressing the underlying cause of hyponatremia.

Immediate Assessment

First, determine if this is symptomatic or asymptomatic hyponatremia. With sodium at 122 mmol/L, look specifically for:

• Altered mental status (somnolence, confusion, obtundation)
• Seizures
• Severe nausea/vomiting
• Cardiorespiratory distress

The low chloride (84 mmol/L) suggests either volume depletion or diuretic use—both common in CKD patients 1.

Treatment Algorithm

If Severely Symptomatic (Medical Emergency)

Administer 100-150 mL bolus of 3% hypertonic saline immediately 2, 3. The goal is to increase sodium by 4-6 mEq/L within 1-2 hours to reverse hyponatremic encephalopathy, but never exceed 10 mEq/L correction in the first 24 hours 2. Rapid intermittent boluses are preferred over continuous infusion for symptomatic cases 3.

• Check sodium every 2 hours initially
• Be prepared to administer hypotonic fluids or desmopressin if overcorrection occurs 3
• In CKD patients with eGFR 30, the risk of overcorrection may be higher due to impaired water handling 1

If Asymptomatic or Mildly Symptomatic

1. Determine volume status clinically:

   • Hypovolemic: Check for diuretic use (thiazides are notorious for causing hyponatremia in CKD 4), vomiting, diarrhea
   • Euvolemic: Consider SIADH (most common)
   • Hypervolemic: Heart failure, cirrhosis

2. Initial management:

   • Fluid restriction to 500 mL/day as first-line therapy 3
   • Ensure adequate solute intake (salt and protein) 3
   • Adjust restriction based on sodium response

3. If fluid restriction fails (occurs in ~50% of SIADH cases 3):

   • Oral urea is considered very effective and safe second-line therapy 2, 3
   • Vaptans are alternative but risk overly rapid correction and increased thirst 2

Critical Considerations for CKD Stage 3b

The eGFR of 30 mL/min/1.73 m² creates unique challenges:

• Impaired ability to regulate water and sodium excretion increases dysnatremia risk 1
• If dialysis becomes necessary for other indications (uremia, hyperkalemia), use ultra-short intermittent hemodialysis sessions with controlled blood flow (220 mL/min), gradual dialysate sodium adjustment, and concomitant dextrose infusion to prevent rapid sodium shifts 5
• Continuous renal replacement therapy offers safer, slower correction if available 6

Common Pitfalls to Avoid

• Do not correct faster than 10 mEq/L in 24 hours even if the patient feels better—osmotic demyelination syndrome can occur days later and cause permanent neurological damage 2
• Do not assume all CKD patients need the same approach—those with higher eGFR may have different mechanisms (enhanced vasopressin activity) versus lower eGFR (impaired diluting capacity) 7
• Review medications immediately—thiazides combined with ACE inhibitors (common in CKD) significantly increase hyponatremia risk 4
• Monitor closely—hyponatremia in CKD is associated with increased mortality and morbidity 1, 8

Underlying Cause Treatment

While correcting sodium, simultaneously treat the root cause:

• Stop offending medications (diuretics, ACE inhibitors temporarily if needed)
• Treat volume depletion with isotonic saline if hypovolemic
• Manage heart failure if hypervolemic
• Address SIADH with fluid restriction and urea if euvolemic

The combination of CKD stage 3b with severe hyponatremia requires meticulous monitoring with sodium checks every 4-6 hours initially, as both overcorrection and undercorrection carry significant risks 3, 5.